ArticleJournal of gastroenterology2021

Direct-acting antivirals improve survival and recurrence rates after treatment of hepatocellular carcinoma within the Milan criteria.

Hironori Ochi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.